KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. Since the discovery of KSHV 20 years ago, there is still no standard treatment and the management of virus-associated malignancies remains toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Coen, Natacha, Duraffour, Sophie, Snoeck, Robert, Andrei, Graciela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246246/
https://www.ncbi.nlm.nih.gov/pubmed/25421895
http://dx.doi.org/10.3390/v6114731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246246/
https://www.ncbi.nlm.nih.gov/pubmed/25421895
http://dx.doi.org/10.3390/v6114731

Ejemplares similares